Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by DaveInCalgaryon Nov 07, 2023 10:09am
82 Views
Post# 35721319

Tilray Brands - German Cannabis Legalization Update

Tilray Brands - German Cannabis Legalization Update
Orginally posted Oct 6, 2023. 
Clearly indicates which laws affect "non-medical" and the Descheduling from Narcotics that affect Tilray's "Medical Cannabis"


Starting next week Germany should be real good for Cannabis 

In August, the federal government passed a “law on the controlled handling of cannabis and changes to other regulations” (CanG), which is expected to come into force at the beginning of 2024.

A
 2-pillar model for the controlled distribution of recreational cannabis to adults .


A livestream on October 10, 2023 from 6:00 p.m. to 7:30 p.m.,
Federal Health Minister Prof. Karl Lauterbach, together with experts, will answer your questions about the specific planned legal changes and the risks of cannabis consumption.

The 2-pillar model for the controlled distribution of recreational cannabis to adults, for non-medical purposes. This law will be officially introduced into the Bundestag on October 13th.

Some Questions & Answers About this New Cannabis Law:

(NOTE:
 49 Questions asked & answered, I only mention those pertaining to Tilray.
all questions here
https://www.bundesgesundheitsministerium.de/themen/cannabis/faq-cannabisgesetz-entwurf.html)

Discussions: Why has the federal government decided to implement the controlled distribution of consumer cannabis to adults

for non-medical purposes (2-pillar Model)

2. When will the law on the controlled distribution of cannabis to adults for non-medical purposes come into effect?
  • Based on the key issues paper of March 24, 2023, the federal government has drawn up a draft bill for Pillar 1 (Cannabis Act: private and community, non-commercial cultivation of cannabis for non-medical purposes) and submitted it to the departmental vote and the consultation process of states and associations at the end of June given. The draft law was approved by the Federal Cabinet on August 16th and subsequently introduced into the parliamentary legislative process. He will be discussed in both the German Bundestag and the Bundesrat in the autumn. The German Bundestag is responsible for making the final decision on the law. The law does not require approval in the Federal Council. It is scheduled to come into force at the beginning of 2024. From the moment it comes into force, adults can legally smoke a joint in Germany under the proposed law. Until then, cannabis remains banned for the time being.
     

    Medical cannabis

    41. Will medical cannabis still be available in pharmacies with a prescription?
     
    • Yes. Medical cannabis should be legally clearly separated from cannabis for non-medical purposes. Medical cannabis is therefore not regulated in the Cannabis Act, but in a separate Medical Cannabis Act. The content of the existing regulations on medical cannabis remains essentially unchanged. Medical cannabis may continue to be prescribed as a medicine in accordance with the applicable social law requirements. However, a prescription for a special narcotic prescription will no longer be necessary in the future. A regular recipe is sufficient here.

      42. Does the law now allow any company to grow medical cannabis?

       

      • No. Cannabis continues to be cultivated by companies that were selected in a Europe-wide tender process and commissioned by the Cannabis Agency at the Federal Institute for Drugs and Medical Devices. This cannabis is grown exclusively for medical purposes in accordance with pharmaceutical quality requirements. The prescription requirement remains.


      NOTE: 

      The 2-pillar model further develops  the federal government's key points for the introduction of the controlled distribution of cannabis to adults from October 26, 2022 . It now provides for two pillars:

      • Pillar 1 enables private cultivation by adults for their own consumption as well as communal, non-commercial cultivation of cannabis in cultivation associations. The draft law on the first pillar (CanG) was  passed by the federal government on August 16, 2023 ( press release from August 16, 2023 ) and subsequently submitted to the parliamentary procedure. The law is scheduled to come into force at the beginning of 2024.
      • Pillar 2 provides for regional model projects with commercial supply chains. The vote on Pillar 2 should follow after the summer break. The draft law is expected to be submitted to the European Commission for consideration.
      • 2nd pillar: Regional model project with commercial supply chains

        In the next step on the way to a nationwide regulation, the second pillar implements the further approaches from the key points paper of October 26, 2022, including an evaluation as a scientifically designed, regionally and time-limited model: companies will control production, sales and distribution in Specialist shops selling recreational cannabis to adults in a licensed and state-controlled framework. This pillar can be used to scientifically examine the effects of a commercial supply chain on health and youth protection as well as the black market.

        • The project duration is 5 years from the supply chain established.
        • There is a spatial limitation to delivery points and adult residents of certain districts/cities in several federal states (opt-in approach).
        • Within the framework of the law, approval of the distribution of edibles will be examined in compliance with strict youth and health protection regulations.
        • The model is scientifically supported and evaluated. The findings will be made available to the European partners and the EU Commission.
        • Health and youth protection also follows the key issues paper of October 26, 2022.

        This part of the project is expected to continue to be subject to notification.

        When implementing the two-pillar model, the Federal Government bases its implementation on the international and EU legal framework. 

Kirsten Kappert-Gonther, MdB, 
Acting Chairperson on the German Health Committee
 
"Anyone who needs Cannabis as Medizin should get it.
That's why we've made it easier to prescribe medicinal cannabis!
We are shortening the reservation of approval, instructing the GBA to define specialist groups in which the reservation of approval is completely eliminated."

Medical Cannabis No Longer Requires a Narcotics Prescription
after January 1, 2024.


I've Got To Admit It's Getting Better
<< Previous
Bullboard Posts
Next >>